Neos

Two Red Hot Biotechs With Big Near-term Catalysts Ahead
Motley Fool
Mon, 05/29/17 - 12:09 pm
biotech
Portola Pharmaceuticals
betrixiban
andexanet alfa
Neos
Adzenys XR-ODT
ADHD
Cotempla XR-OTD
Concerta
It’s tasty and easy to take. And that’s why a new ADHD drug alarms some psychiatrists
Stat
Mon, 05/23/16 - 07:12 pm
ADHD
Neos
Adzenys
Neos Therapeutics: On The Right Track, But Don't Expect Much From Adzenys This Year
Seeking Alpha
Fri, 05/20/16 - 10:32 am
Neos
Adzenys
ADHD
FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval
Fierce Biotech
Tue, 10/20/15 - 09:44 am
FDA
Neos
Ritalin
ADHD
Cotempla XR-ODT
Neos pulls off a $72M IPO to push its ADHD drugs forward
Fierce Biotech
Fri, 07/24/15 - 05:47 pm
Neos
IPOs
ADHD
Neos angles for a $74M IPO to fund its ADHD drugs
Fierce Biotech
Mon, 07/13/15 - 11:44 am
Neos
ADHD
IPOs